{ "company_number": "07533771", "name": "Winzor Pharmaceuticals UK Limited", "url": "/company/07533771", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2011-02-17", "dissolved_on": null, "sic_codes": [ { "code": "32990", "description": "Other manufacturing n.e.c.", "section": "C", "section_name": "Manufacturing", "url": "/sic/32990" } ], "registered_address": { "id": 692785, "url": "/address/692785", "line1": "25 CHESS BUSINESS PARK", "line2": "MOOR ROAD", "post_town": "CHESHAM", "county": "BUCKINGHAMSHIRE", "country": "ENGLAND", "postcode": "HP5 1SD" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07533771", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2026-11-30", "last_made_up": "2025-02-28", "category": "TOTAL EXEMPTION FULL", "filings": [ { "url": "/company/07533771/accounts/2025-02-28", "pdf_url": "/company/07533771/accounts/2025-02-28.pdf", "made_up_date": "2025-02-28", "period_start": "2024-03-01", "period_end": "2025-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": "35.00", "tangible_fixed_assets": "804961.00", "debtors": "424673.00", "cash_bank_in_hand": "174714.00", "current_assets": "937711.00", "creditors_due_within_one_year": "60931.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "876780.00", "total_assets_less_current_liabilities": "1681741.00", "net_assets_liabilities": "1195483.00", "called_up_share_capital": "99.00", "profit_loss_account_reserve": "1195384.00", "shareholder_funds": "99.00", "turnover": "1878884.00", "other_operating_income": null, "cost_sales": "1056523.00", "gross_profit_loss": "822361.00", "administrative_expenses": "795977.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "26384.00", "profit_before_tax": "26384.00", "tax_on_profit": "1514.00", "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2025.zip" }, { "url": "/company/07533771/accounts/2024-02-29", "pdf_url": "/company/07533771/accounts/2024-02-29.pdf", "made_up_date": "2024-02-29", "period_start": "2023-03-01", "period_end": "2024-02-29", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": "20.00", "tangible_fixed_assets": "804961.00", "debtors": "254991.00", "cash_bank_in_hand": "185758.00", "current_assets": "929073.00", "creditors_due_within_one_year": "77163.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "851910.00", "total_assets_less_current_liabilities": "1656871.00", "net_assets_liabilities": "1170613.00", "called_up_share_capital": "99.00", "profit_loss_account_reserve": "1170514.00", "shareholder_funds": "99.00", "turnover": "1578227.00", "other_operating_income": null, "cost_sales": "765812.00", "gross_profit_loss": "812415.00", "administrative_expenses": "800167.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "12248.00", "profit_before_tax": "12248.00", "tax_on_profit": "2327.00", "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2024.zip" }, { "url": "/company/07533771/accounts/2023-02-28", "pdf_url": "/company/07533771/accounts/2023-02-28.pdf", "made_up_date": "2023-02-28", "period_start": "2023-02-28", "period_end": "2023-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": "24.00", "tangible_fixed_assets": "827401.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "937055.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "819549.00", "total_assets_less_current_liabilities": "1646950.00", "net_assets_liabilities": "1160692.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "1160692.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2023.zip" }, { "url": "/company/07533771/accounts/2022-02-28", "pdf_url": "/company/07533771/accounts/2022-02-28.pdf", "made_up_date": "2022-02-28", "period_start": "2021-03-01", "period_end": "2022-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": "47.00", "tangible_fixed_assets": "804961.00", "debtors": "192690.00", "cash_bank_in_hand": "294609.00", "current_assets": "984004.00", "creditors_due_within_one_year": "170911.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "813093.00", "total_assets_less_current_liabilities": "1618054.00", "net_assets_liabilities": "1131796.00", "called_up_share_capital": "99.00", "profit_loss_account_reserve": "1131697.00", "shareholder_funds": "99.00", "turnover": "1905000.00", "other_operating_income": null, "cost_sales": "784261.00", "gross_profit_loss": "1120739.00", "administrative_expenses": "979698.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "141041.00", "profit_before_tax": "141041.00", "tax_on_profit": "26798.00", "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-September2022.zip" }, { "url": "/company/07533771/accounts/2021-02-28", "pdf_url": "/company/07533771/accounts/2021-02-28.pdf", "made_up_date": "2021-02-28", "period_start": "2021-02-28", "period_end": "2021-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": "35.00", "tangible_fixed_assets": "804961.00", "debtors": "87691.00", "cash_bank_in_hand": "608177.00", "current_assets": "916059.00", "creditors_due_within_one_year": "217209.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "698850.00", "total_assets_less_current_liabilities": "1503811.00", "net_assets_liabilities": "1017553.00", "called_up_share_capital": "99.00", "profit_loss_account_reserve": "1017454.00", "shareholder_funds": "99.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2021.zip" }, { "url": "/company/07533771/accounts/2020-02-29", "pdf_url": "/company/07533771/accounts/2020-02-29.pdf", "made_up_date": "2020-02-29", "period_start": "2019-03-01", "period_end": "2020-02-29", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": "25.00", "tangible_fixed_assets": "777955.00", "debtors": "121116.00", "cash_bank_in_hand": "667717.00", "current_assets": "959024.00", "creditors_due_within_one_year": "498513.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "460511.00", "total_assets_less_current_liabilities": "1238466.00", "net_assets_liabilities": "752208.00", "called_up_share_capital": "99.00", "profit_loss_account_reserve": "752109.00", "shareholder_funds": "99.00", "turnover": "2620313.00", "other_operating_income": null, "cost_sales": "1533712.00", "gross_profit_loss": "1086601.00", "administrative_expenses": "795752.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "290849.00", "profit_before_tax": "290849.00", "tax_on_profit": "31305.00", "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2020.zip" }, { "url": "/company/07533771/accounts/2019-02-28", "pdf_url": "/company/07533771/accounts/2019-02-28.pdf", "made_up_date": "2019-02-28", "period_start": "2019-02-28", "period_end": "2019-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "648822.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "665566.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "251443.00", "total_assets_less_current_liabilities": "900265.00", "net_assets_liabilities": "414007.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "414007.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2019.zip" }, { "url": "/company/07533771/accounts/2018-02-28", "pdf_url": "/company/07533771/accounts/2018-02-28.pdf", "made_up_date": "2018-02-28", "period_start": "2018-02-28", "period_end": "2018-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "648822.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "565566.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "151443.00", "total_assets_less_current_liabilities": "800265.00", "net_assets_liabilities": "314007.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "314007.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2018.zip" }, { "url": "/company/07533771/accounts/2016-02-29", "pdf_url": "/company/07533771/accounts/2016-02-29.pdf", "made_up_date": "2016-02-29", "period_start": "2016-02-29", "period_end": "2016-02-29", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "334109.00", "debtors": "228437.00", "cash_bank_in_hand": "178349.00", "current_assets": "486540.00", "creditors_due_within_one_year": "24005.00", "creditors_due_after_one_year": "656799.00", "net_current_assets_liabilities": "462535.00", "total_assets_less_current_liabilities": "796644.00", "net_assets_liabilities": "139845.00", "called_up_share_capital": "99.00", "profit_loss_account_reserve": "139746.00", "shareholder_funds": "139845.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-December2016.zip" }, { "url": "/company/07533771/accounts/2015-02-28", "pdf_url": "/company/07533771/accounts/2015-02-28.pdf", "made_up_date": "2015-02-28", "period_start": "2015-02-28", "period_end": "2015-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "318529.00", "cash_bank_in_hand": "389062.00", "current_assets": "779889.00", "creditors_due_within_one_year": "19266.00", "creditors_due_after_one_year": "656799.00", "net_current_assets_liabilities": "760623.00", "total_assets_less_current_liabilities": "760623.00", "net_assets_liabilities": "103824.00", "called_up_share_capital": "99.00", "profit_loss_account_reserve": "103725.00", "shareholder_funds": "103824.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2015.zip" }, { "url": "/company/07533771/accounts/2014-02-28", "pdf_url": "/company/07533771/accounts/2014-02-28.pdf", "made_up_date": "2014-02-28", "period_start": "2014-02-28", "period_end": "2014-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "105508.00", "cash_bank_in_hand": "569081.00", "current_assets": "770825.00", "creditors_due_within_one_year": "12341.00", "creditors_due_after_one_year": "671723.00", "net_current_assets_liabilities": "758484.00", "total_assets_less_current_liabilities": "758484.00", "net_assets_liabilities": "86761.00", "called_up_share_capital": "99.00", "profit_loss_account_reserve": "86662.00", "shareholder_funds": "86761.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2015.zip" }, { "url": "/company/07533771/accounts/2013-02-28", "pdf_url": "/company/07533771/accounts/2013-02-28.pdf", "made_up_date": "2013-02-28", "period_start": "2013-02-28", "period_end": "2013-02-28", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "135378.00", "cash_bank_in_hand": "258742.00", "current_assets": "456120.00", "creditors_due_within_one_year": "22524.00", "creditors_due_after_one_year": "396197.00", "net_current_assets_liabilities": "433596.00", "total_assets_less_current_liabilities": "433596.00", "net_assets_liabilities": "37399.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "37299.00", "shareholder_funds": "37399.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2013.zip" }, { "url": "/company/07533771/accounts/2012-02-29", "pdf_url": "/company/07533771/accounts/2012-02-29.pdf", "made_up_date": "2012-02-29", "period_start": "2012-02-29", "period_end": "2012-02-29", "entity_name": "Winzor Pharmaceuticals UK Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": "81347.00", "cash_bank_in_hand": "18619.00", "current_assets": "211966.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "197338.00", "total_assets_less_current_liabilities": "197338.00", "net_assets_liabilities": "5714.00", "called_up_share_capital": "1.00", "profit_loss_account_reserve": "5713.00", "shareholder_funds": "5714.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "xml", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2012.zip" } ], "pdf_only_filings": [ { "made_up_date": "2017-02-28", "filing_date": "2018-01-17", "form_type": "AA", "description": "accounts-with-accounts-type-total-exemption-full", "paper_filed": true, "pdf_url": "/company/07533771/accounts/2017-02-28.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/07533771/filing-history/MzE5NTI4NDg1OGFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/07533771/filing-history" }, "confirmation_statement": { "next_due": "2027-05-26", "last_made_up": "2026-05-12" }, "officers": [], "psc": [ { "name": "Mr Taghlub Al-Kass", "kind": "individual-person-with-significant-control", "person_url": "/person/4922535", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-09-19", "ceased_on": "2026-05-01", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Ms Dana Al-Kass", "kind": "individual-person-with-significant-control", "person_url": "/person/1060813", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-06-01", "ceased_on": "2026-05-13", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Taghlub Al-Kass", "kind": "individual-person-with-significant-control", "person_url": "/person/4922535", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-06-01", "ceased_on": "2026-07-04", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Ms Tara Al-Kass", "kind": "individual-person-with-significant-control", "person_url": "/person/4940781", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-06-01", "ceased_on": "2026-07-04", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Ms Tara Al-Kass", "kind": "individual-person-with-significant-control", "person_url": "/person/4940781", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Ms Dana Al-Kass", "kind": "individual-person-with-significant-control", "person_url": "/person/1060813", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Taghlub Al-Kass", "kind": "individual-person-with-significant-control", "person_url": "/person/4922535", "controlling_company_url": null, "natures_of_control": [ "ownership-of-shares-25-to-50-percent" ], "notified_on": "2016-04-06", "ceased_on": null, "nationality": "British", "country_of_residence": "England", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-08-01", "retrieved_at": "2026-08-14T22:43:52.697050+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }